- Wearable Devices
- Conventional Devices
- Implantable Devices
Epilepsy Monitoring Devices Market size is valued at USD 525 million in 2022 and is poised to grow at a significant CAGR of 4.9% over 2023–2029. Epilepsy is a neurological disorder, it affects the central nervous system in which brain activity becomes abnormal, causing seizures or periods of unusual behaviour, sensations, temporary confusion, uncontrollable jerking movements of arms and legs, and loss of awareness. Anyone can develop epilepsy irrespective of males and females of all races, ethnic backgrounds, and ages. According to WHO, around 50 million people worldwide have epilepsy, and nearly 80% of people with epilepsy live in low- and middle-income countries. It is estimated that up to 70% of people living with epilepsy could live seizure-free if properly diagnosed and treated. The increasing prevalence of epilepsy and incidence of head injuries, brain cancer, and infections are driving the epilepsy monitoring devices market share. Around 5 million people are diagnosed with epilepsy each year worldwide. Moreover, the rise in research & development activities with the immense investment and the awareness about epilepsy monitoring devices is expected to increase the epilepsy devices market demand. Various awareness programs organized by organizations and government initiatives will further increase the awareness and growth of the market. However, the high cost of complex epilepsy monitoring procedures and devices is a significant restrain that limits the market growth. For instance, handling MEG devices is very challenging for healthcare facilities in countries that have implemented this monitoring equipment. Although increasing demand for non-invasive and minimally invasive devices shows the opportunity in the global epilepsy monitoring devices market trends. Invasive monitoring is a very risky, intricate, and painful process that needs direct intervention with the brain's sensitive tissues. As a result, patients and doctors are more interested in using minimally or non-invasive epilepsy monitoring technologies.
Epilepsy Monitoring Devices Market Key Developments:
In Feb 2022, Angelini Pharma, an international Italian pharmaceutical company, announced that it would provide patients and healthcare professionals with innovative solutions to improve the care of patients with epilepsy.
In January 2021, Nihon Kohden launched disposable EEG electrodes to help prevent cross-contamination between patients and healthcare workers.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Increasing incidence and prevalence of epilepsy are driving the growth of the global epilepsy monitoring devices market due to the increasing brain injuries, increased risk of neurocysticercosis, the higher incidence of road traffic injuries and birth-related injuries, variations in medical infrastructure, and the availability of preventive health programs and accessible care. According to CDC, about 0.6% of children aged 0-17 years have active epilepsy.
The epilepsy monitoring devices market is projected to expand at a CAGR of 4.9% during the forecast period
Koninklijke Philips N.V, Natus Medical, Inc. (US), Compumedics Limited (Australia), Empatica, Inc. (US), Abbott Laboratories, Inc. (US), LivAssured B.V. (Netherlands), BioSerenity (France), The Magstim Co. Ltd. (UK), Nihon Kohden Corporation (Japan)
North America is the fastest-growing region for epilepsy monitoring devices market
1. Executive Summary |
2. Global Epilepsy Monitoring Devices Market Introduction |
2.1. Global Epilepsy Monitoring Devices Market – Taxonomy |
2.2. Global Epilepsy Monitoring Devices Market –Definitions |
2.2.1. By Product |
2.2.2. By Technology |
2.2.3. By End User |
2.2.4. By Region |
3. Global Epilepsy Monitoring Devices Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Epilepsy Monitoring Devices Market Dynamic Factors - Impact Analysis |
3.6. Global Epilepsy Monitoring Devices Market – Competition Landscape |
3.7. Epidemiology |
4. Global Epilepsy Monitoring Devices Market Analysis, 2017-2021 and Forecast, 2022-2028 |
4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Epilepsy Monitoring Devices Market, By Product, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.1. Wearable Devices |
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Conventional Devices |
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Implantable Devices |
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6. Global Epilepsy Monitoring Devices Market, By Technology, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.1. Vagus Nerve Stimulation (VNS) |
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Responsive Neurostimulation |
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Deep Brain Stimulation |
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Accelerometry |
6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
7. Global Epilepsy Monitoring Devices Market, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.1. Hospitals and Clinics |
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Ambulatory Surgery Centers |
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Neurology Centers |
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Diagnostic Centers |
7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Home Care Settings |
7.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8. Global Epilepsy Monitoring Devices Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
8.1. North America |
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia-Pacific |
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Latin America |
8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Middle East and Africa |
8.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
8.6. Global Epilepsy Monitoring Devices Market - Opportunity Analysis Index, By Product, By Technology, By End User, and Region, 2022-2028 |
9. North America Epilepsy Monitoring Devices Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
9.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
9.1.1. Wearable Devices |
9.1.2. Conventional Devices |
9.1.3. Implantable Devices |
9.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
9.2.1. Vagus Nerve Stimulation (VNS) |
9.2.2. Responsive Neurostimulation |
9.2.3. Deep Brain Stimulation |
9.2.4. Accelerometry |
9.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
9.3.1. Hospitals and Clinics |
9.3.2. Ambulatory Surgery Centers |
9.3.3. Neurology Centers |
9.3.4. Diagnostic Centers |
9.3.5. Home Care Settings |
9.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
9.4.1. USA |
9.4.2. Canada |
9.5. North America Epilepsy Monitoring Devices Market - Opportunity Analysis Index, By Product, By Technology, By End User, and Country, 2022-2028 |
9.6. North America Epilepsy Monitoring Devices Market Dynamics – Trends |
10. Europe Epilepsy Monitoring Devices Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
10.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Wearable Devices |
10.1.2. Conventional Devices |
10.1.3. Implantable Devices |
10.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.2.1. Vagus Nerve Stimulation (VNS) |
10.2.2. Responsive Neurostimulation |
10.2.3. Deep Brain Stimulation |
10.2.4. Accelerometry |
10.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.3.1. Hospitals and Clinics |
10.3.2. Ambulatory Surgery Centers |
10.3.3. Neurology Centers |
10.3.4. Diagnostic Centers |
10.3.5. Home Care Settings |
10.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
10.4.1. Germany |
10.4.2. UK |
10.4.3. France |
10.4.4. Spain |
10.4.5. Italy |
10.4.6. Rest of Europe |
10.5. Europe Epilepsy Monitoring Devices Market - Opportunity Analysis Index, By Product, By Technology, By End User, and Country, 2022-2028 |
10.6. Europe Epilepsy Monitoring Devices Market Dynamics – Trends |
11. Asia-Pacific Epilepsy Monitoring Devices Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
11.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Wearable Devices |
11.1.2. Conventional Devices |
11.1.3. Implantable Devices |
11.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.2.1. Vagus Nerve Stimulation (VNS) |
11.2.2. Responsive Neurostimulation |
11.2.3. Deep Brain Stimulation |
11.2.4. Accelerometry |
11.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.3.1. Hospitals and Clinics |
11.3.2. Ambulatory Surgery Centers |
11.3.3. Neurology Centers |
11.3.4. Diagnostic Centers |
11.3.5. Home Care Settings |
11.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.4.1. China |
11.4.2. India |
11.4.3. Japan |
11.4.4. ASEAN |
11.4.5. Australia & New Zealand |
11.4.6. Rest of Asia-Pacific |
11.5. Asia-Pacific Epilepsy Monitoring Devices Market - Opportunity Analysis Index, By Product, By Technology, By End User, and Country, 2022-2028 |
11.6. Asia-Pacific Epilepsy Monitoring Devices Market Dynamics – Trends |
12. Latin America Epilepsy Monitoring Devices Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
12.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Wearable Devices |
12.1.2. Conventional Devices |
12.1.3. Implantable Devices |
12.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.2.1. Vagus Nerve Stimulation (VNS) |
12.2.2. Responsive Neurostimulation |
12.2.3. Deep Brain Stimulation |
12.2.4. Accelerometry |
12.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.3.1. Hospitals and Clinics |
12.3.2. Ambulatory Surgery Centers |
12.3.3. Neurology Centers |
12.3.4. Diagnostic Centers |
12.3.5. Home Care Settings |
12.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.4.1. Brazil |
12.4.2. Mexico |
12.4.3. Rest of Latin America |
12.5. Latin America Epilepsy Monitoring Devices Market - Opportunity Analysis Index, By Product, By Technology, By End User, and Country, 2022-2028 |
12.6. Latin America Epilepsy Monitoring Devices Market Dynamics – Trends |
13. Middle East and Africa Epilepsy Monitoring Devices Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
13.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Wearable Devices |
13.1.2. Conventional Devices |
13.1.3. Implantable Devices |
13.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.2.1. Vagus Nerve Stimulation (VNS) |
13.2.2. Responsive Neurostimulation |
13.2.3. Deep Brain Stimulation |
13.2.4. Accelerometry |
13.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.3.1. Hospitals and Clinics |
13.3.2. Ambulatory Surgery Centers |
13.3.3. Neurology Centers |
13.3.4. Diagnostic Centers |
13.3.5. Home Care Settings |
13.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
13.4.1. Gulf Cooperation Council (GCC) Countries |
13.4.2. South Africa |
13.4.3. Rest of MEA |
13.5. MEA Epilepsy Monitoring Devices Market - Opportunity Analysis Index, By Product, By Technology, By End User, and Country, 2022-2028 |
13.6. MEA Epilepsy Monitoring Devices Market Dynamics – Trends |
14. Competition Landscape |
14.1. Strategic Dashboard of Top Market Players |
14.2. Company Profiles (Introduction, Financial Analysis, Key Products, Key Developments, Strategies, and SWOT Analysis) |
14.2.1. Koninklijke Philips N.V |
14.2.2. Natus Medical, Inc. (US) |
14.2.3. Compumedics Limited (Australia) |
14.2.4. Empatica, Inc. (US) |
14.2.5. Abbott Laboratories, Inc. (US) |
14.2.6. LivAssured B.V. (Netherlands) |
14.2.7. BioSerenity (France) |
14.2.8. The Magstim Co. Ltd. (UK) |
14.2.9. Nihon Kohden Corporation (Japan) |
14.2.10. Medtronic Plc (Ireland) |
14.2.11. Masimo Corporation (US) |
14.2.12. Boston Scientific Corporation (US) |
14.2.13. Aleva Neurotherapeutics (Switzerland) |
14.2.14. Medpage, Ltd. (UK) |
14.2.15. Neurosoft (Russia) |
15. Research Methodology |
16. Key Assumptions and Acronyms |